Pursuant to Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, Sunil Healthcare has informed that the 246th Meeting of the Board of Directors of the Company, which is scheduled to be held on Wednesday, October 27, 2021 at 03:15 pm at Registered office 38E/252A, Vijay Tower, 3rd Floor, Panchsheel Commercial Complex, Shahpur Jat, New Delhi-110049 (deemed venue), through video conferencing/ Audio visual connection, to consider, approve and take on record the Un-audited Financial Results (both standalone and consolidated) for the 2nd quarter/ 1st half year ended on September 30, 2021 of the Financial Year 2021-22. Further, the Trading Window under the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 as already intimated on 01.10.2021 through its letter dated 30.09.2021, shall remain close from October 01, 2021 till October 29, 2021.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| BASF India | 3628.65 |
| Tata Chemicals | 801.15 |
| SRF | 2527.60 |
| Pidilite Inds. | 1363.45 |
| Deepak Nitrite | 1771.15 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: